News & Press

Two Companies Win Biodefense Contracts

Chemical & Engineering News mentions Lybradyn SBIR grant from NIH.
Read the article (November 7, 2005)

Lybradyn Awarded Phase I SBIR Grant From National Institutes of Health

The grant was awarded to develop new organophosphorous hydrolases (OPH’s) for the biocatalytic degradation of chemical warfare agents and pesticides.
Read the press release (September 2, 2005)

Lybradyn, Inc. Graduates From Chicago Technology Park; Pharmain, Ltd, Secures Laboratory Space

"The Illinois Medical District Commission today announced that Lybradyn, Inc. has graduated from the Chicago Technology Park (CTP) Research Center and that PharmaIn, Ltd. has moved into the facility."
Read the press release (February 9, 2005)

Former employees of Chicago-area contract research firm MediChem strike out on their own

"If they are not starting new companies, former MediChem people are joining other new Chicago-area firms. One is Lybradyn, a biotechnology company that is developing products through the integration of genetic engineering and fermentation."
Read the full article on the Chemical & Engineering News website.